Jean Coutu sales up but profit weighed by generic prices - BNN Bloomberg

The Quebec-based pharmacy company had $47.8 million or 26 cents per share of net income in its fourth quarter, ended March 4 — down seven per cent from the comparable period last year.

Novo Nordisk Forecasts Record Profit Fueled by Obesity Drug - Bloomberg

Metro makes formal $4.5B cash and stock offer for Jean Coutu - BNN Bloomberg

China's Industrial Profits Jump Though Deflation Woes Linger - Bloomberg

Stock analysis - including stock price, stock chart, company news, key statistics

Billionaires Buffett, Griffin and Cohen Agree: Tokyo's Worth Revisiting - Bloomberg

Solved Assume that projected revenue for 2018 is 1,231,414.

Novo Signs $1.1 Billion Obesity R&D Deals With Two Biotechs - Bloomberg

Corporate Profits Drive 60% of Inflation Increases

Jean Coutu profits up despite generics

Cargojet cutting costs as it reports Q2 profit and revenue down from year ago mark - BNN Bloomberg

Business and Finance News

Bulletin Daily Paper 08/13/12 by Western Communications, Inc. - Issuu

Jean Coutu sales up but profit weighed by generic prices - BNN

Grocers brace for generic drug deal; Loblaw stock downgraded by Desjardins - BNN Bloomberg